Stephen D. Shafran

4.3k total citations
89 papers, 2.6k citations indexed

About

Stephen D. Shafran is a scholar working on Epidemiology, Infectious Diseases and Hepatology. According to data from OpenAlex, Stephen D. Shafran has authored 89 papers receiving a total of 2.6k indexed citations (citations by other indexed papers that have themselves been cited), including 59 papers in Epidemiology, 36 papers in Infectious Diseases and 31 papers in Hepatology. Recurrent topics in Stephen D. Shafran's work include Hepatitis C virus research (31 papers), HIV/AIDS drug development and treatment (20 papers) and Liver Disease Diagnosis and Treatment (20 papers). Stephen D. Shafran is often cited by papers focused on Hepatitis C virus research (31 papers), HIV/AIDS drug development and treatment (20 papers) and Liver Disease Diagnosis and Treatment (20 papers). Stephen D. Shafran collaborates with scholars based in Canada, United States and France. Stephen D. Shafran's co-authors include Roger Sandre, Hongmei Mo, Christine Hughes, Evguenia S. Svarovskaia, Charlotte Hedskog, Peter Phillips, Robert H. Hyland, Sergio Borgia, Diana M. Brainard and Bandita Parhy and has published in prestigious journals such as New England Journal of Medicine, SHILAP Revista de lepidopterología and Annals of Internal Medicine.

In The Last Decade

Stephen D. Shafran

87 papers receiving 2.5k citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
Stephen D. Shafran Canada	25	1.9k	994	830	246	192	89	2.6k
W. James Alexander United States	17	1.5k 0.8×	1.3k 1.4×	364 0.4×	330 1.3×	184 1.0×	32	3.2k
Mallory D. Witt United States	37	1.7k 0.9×	469 0.5×	2.7k 3.3×	88 0.4×	146 0.8×	138	4.8k
Sheldon T. Brown United States	34	2.1k 1.1×	509 0.5×	1.7k 2.0×	54 0.2×	252 1.3×	113	4.0k
José L. Casado Spain	31	1.3k 0.7×	478 0.5×	2.3k 2.8×	145 0.6×	192 1.0×	189	3.7k
N. Singh United States	33	2.4k 1.3×	219 0.2×	2.0k 2.5×	150 0.6×	147 0.8×	90	3.5k
Guglielmo Borgia Italy	31	1.4k 0.7×	1.4k 1.4×	628 0.8×	68 0.3×	81 0.4×	122	2.5k
Amy Weintrob United States	34	1.6k 0.9×	447 0.4×	1.6k 1.9×	38 0.2×	322 1.7×	98	4.0k
Ivan Gentile Italy	33	1.6k 0.8×	1.3k 1.3×	1.1k 1.4×	58 0.2×	105 0.5×	202	3.3k
Muriel Vray France	26	799 0.4×	519 0.5×	852 1.0×	86 0.3×	203 1.1×	96	2.2k
Víctor Asensi Spain	25	963 0.5×	604 0.6×	711 0.9×	26 0.1×	210 1.1×	128	2.3k

Countries citing papers authored by Stephen D. Shafran

Since Specialization

Citations

This map shows the geographic impact of Stephen D. Shafran's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Stephen D. Shafran with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Stephen D. Shafran more than expected).

Fields of papers citing papers by Stephen D. Shafran

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Stephen D. Shafran. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Stephen D. Shafran. The network helps show where Stephen D. Shafran may publish in the future.

Co-authorship network of co-authors of Stephen D. Shafran

This figure shows the co-authorship network connecting the top 25 collaborators of Stephen D. Shafran. A scholar is included among the top collaborators of Stephen D. Shafran based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Stephen D. Shafran. Stephen D. Shafran is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

Shafran, Stephen D.. (2015). HIV Coinfected Have Similar SVR Rates as HCV Monoinfected With DAAs: It's Time to End Segregation and Integrate HIV Patients Into HCV Trials. Clinical Infectious Diseases. 61(7). 1127–1134. 19 indexed citations

Sulkowski, Mark S., Marc Bourlière, Jean-Pierre Bronowicki, et al.. (2013). Faldaprevir combined with peginterferon alfa-2a and ribavirin in chronic hepatitis C virus genotype-1 patients with prior nonresponse: SILEN-C2 trial. Hepatology. 57(6). 2155–2163. 60 indexed citations

Hull, Mark, Marina B. Klein, Stephen D. Shafran, et al.. (2013). CIHR Canadian HIV Trials Network Coinfection and Concurrent Diseases Core: Canadian Guidelines for Management and Treatment of HIV/Hepatitis C Coinfection in Adults. Canadian Journal of Infectious Diseases and Medical Microbiology. 24(4). 217–238. 9 indexed citations

Gorfinkel, Iris, F. Y. Aoki, Shelly McNeil, et al.. (2013). Seroprevalence of HSV-1 and HSV-2 antibodies in Canadian women screened for enrolment in a herpes simplex virus vaccine trial. International Journal of STD & AIDS. 24(5). 345–349. 11 indexed citations

Bow, Eric J., Gerald A. Evans, Jeff Fuller, et al.. (2010). Canadian Clinical Practice Guidelines for Invasive Candidiasis in Adults. Canadian Journal of Infectious Diseases and Medical Microbiology. 21(4). e122–50. 43 indexed citations

Loutfy, Mona, Tony Antoniou, Jean-Guy Baril, et al.. (2007). Randomized Controlled Trial of Once-Daily Tenofovir, Lamivudine, and Lopinavir/Ritonavir Versus Remaining on the Same Regimen in Virologically Suppressed HIV-Infected Patients on Their First PI-Containing HAART Regimen. HIV Clinical Trials. 8(5). 259–268. 3 indexed citations

Lalonde, Richard, Jean Deschênes, William Hodge, et al.. (2004). Canadian Consensus Guidelines for the Management of Cytomegalovirus Disease in HIV/AIDS. Canadian Journal of Infectious Diseases and Medical Microbiology. 15(6). 327–335. 13 indexed citations

Baril, Jean-Guy, Éric Lefebvre, Richard Lalonde, Stephen D. Shafran, & Brian Conway. (2003). Nelfinavir and Non‐Nucleoside Reverse Transcriptase Inhibitor‐Based Salvage Regimes in Heavily Hiv Pretreated Patients. Canadian Journal of Infectious Diseases and Medical Microbiology. 14(4). 201–205. 3 indexed citations

Shafran, Stephen D., et al.. (2003). Once, twice, or three times daily famciclovir compared with aciclovir for the oral treatment of herpes zoster in immunocompetent adults: a randomized, multicenter, double-blind clinical trial. Journal of Clinical Virology. 29(4). 248–253. 52 indexed citations

10.

Tyring, Stephen K., Francisco Díaz‐Mitoma, Stephen D. Shafran, et al.. (2003). Oral Famciclovir for the Suppression of Recurrent Genital Herpes: The Combined Data from Two Randomized Controlled Trials. Journal of Cutaneous Medicine and Surgery. 7(6). 449–454. 10 indexed citations

11.

Swiston, John R., et al.. (2001). Isolated Native Tricuspid Valve Endocarditis Caused by Viridans Streptococcus. Canadian Journal of Infectious Diseases and Medical Microbiology. 12(5). 305–307. 4 indexed citations

12.

Gordin, Fred M., Paul M. Sullam, Stephen D. Shafran, et al.. (1999). A Randomized, Placebo‐Controlled Study of Rifabutin Added to a Regimen of Clarithromycin and Ethambutol for Treatment of Disseminated Infection with Mycobacterium avium Complex. Clinical Infectious Diseases. 28(5). 1080–1085. 92 indexed citations

13.

Shafran, Stephen D., Joel Singer, Donald P. Zarowny, et al.. (1998). Determinants of Rifabutin‐Associated Uveitis in Patients Treated with Rifabutin, Clarithromycin, and Ethambutol forMycobacterium aviumComplex Bacteremia: A Multivariate Analysis. The Journal of Infectious Diseases. 177(1). 252–255. 35 indexed citations

14.

Saginur, Raphael, Gary Garber, Gail Darling, et al.. (1996). Prospective, Randomized Comparison of Intravenous and Oral Ciprofloxacin with Intravenous Ceftazidime in the Treatment of Nosocomial Pneumonia. Canadian Journal of Infectious Diseases and Medical Microbiology. 8(2). 89–94. 11 indexed citations

15.

Sandre, Roger & Stephen D. Shafran. (1996). Infective Endocarditis: Review of 135 Cases over 9 Years. Clinical Infectious Diseases. 22(2). 276–286. 206 indexed citations

16.

Shafran, Stephen D., et al.. (1996). A B C D E F G …. Canadian Journal of Infectious Diseases and Medical Microbiology. 7(3). 181–182. 19 indexed citations

17.

Shafran, Stephen D., Joel Singer, Donald P. Zarowny, et al.. (1996). A Comparison of Two Regimens for the Treatment ofMycobacterium aviumComplex Bacteremia in AIDS: Rifabutin, Ethambutol, and Clarithromycin versus Rifampin, Ethambutol, Clofazimine, and Ciprofloxacin. New England Journal of Medicine. 335(6). 377–384. 208 indexed citations

18.

Conly, John & Stephen D. Shafran. (1994). Intravenous‐to‐Oral Conversion Therapy for Antimicrobials. Canadian Journal of Infectious Diseases and Medical Microbiology. 5(1). 15–16. 3 indexed citations

19.

Garber, Gary, et al.. (1992). A multicenter, open comparative study of parenteral cefotaxime and ceftriaxone in the treatment of nosocomial lower respiratory tract infections. Diagnostic Microbiology and Infectious Disease. 15(1). 85–88. 14 indexed citations

20.

Mah, Manuel W. & Stephen D. Shafran. (1990). Polymicrobial Endocarditis with Eight Pathogens in an Intravenous Drug Abuser. Scandinavian Journal of Infectious Diseases. 22(6). 735–737. 13 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact